Only institutions that have developed a program advancing research in antimicrobial resistance are recognized with a center of excellence designation from the IDSA.
The program within hospitals must also be led by infectious diseases-trained physicians and pharmacists and align with national guidance, according to the July 29 news release.
“Solving the next public health emergency starts with addressing the threat of antimicrobial resistance at every level,” Steven Schmitt, MD, president of IDSA said in the release. “These eight institutions are working to counter the growing problem of resistance, one of the greatest threats facing our future.”
Recipient hospitals research must demonstrate best practices to “slow the emergence of resistance, optimize the treatment of infections, reduce adverse events associated with antibiotic use and to address other challenging areas related to antimicrobial stewardship,” according to the release.
The following eight hospitals were selected for their work in this area by a panel of IDSA member and infectious diseases-trained physicians and pharmacists:
- Baptist Health in Jacksonville, Fla.
- Children’s Hospital New Orleans (La.)
- John D. Dingell VA Medical Center in Detroit, Mich.
- Keck Hospital of USC (University of Southern California) in Los Angeles
- Lake Cumberland Regional Hospital in Somerset, Ky.
- Ocean University Medical Center in Brick Township, N.J.
- University of Southern California (USC) Norris Cancer Hospital in Los Angeles
- University of Toledo (Ohio) Medical Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
